Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome

Abstract

Background

Wiedemann-Rautenstrauch syndrome (WRS) is a rare autosomal recessive neonatal progeroid disorder characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, and mental impairment.

Case presentation

A 6-year-old patient, who initially presented with multiple postnatal abnormalities, facial dysplasia, micrognathia, skull appearance, hallux valgus, and congenital dislocation of the hip, was recruited in this study. The patient was initially diagnosed with progeria. The mother of the patient had abnormal fetal development during her second pregnancy check-up, and the clinical phenotype of the fetus was similar to that of the patient. Whole-exome sequencing (WES) of the patient was performed, and POLR3B compound heterozygous variants—c.2191G > C:p.E731Q and c.3046G > A:p.V1016M—were identified in the patient. Using Sanger sequencing, we found that the phenotypes and genotypes were segregated within the pedigree. These two variants are novel and not found in the gnomAD and 1000 Genomes databases. The two mutation sites are highly conserved between humans and zebrafish.

Conclusions

Our study not only identified a novel WRS-associated gene, POLR3B, but also broadened the mutational and phenotypic spectra of POLR3B. Furthermore, WES may be useful for identifying rare disease-related genetic variants.

Background

Progeria, also known as premature aging syndrome, accelerates the aging of newborns. Characteristic facial features include a larger head, narrow nose bridge, narrow nasal tip, thin vermilion of the upper and lower lips, and a small mouth [1, 2]. Common symptoms include decreased subcutaneous fat, delayed eruption and loss of primary teeth, abnormal skin on the abdomen and upper thighs, early hair loss, nail dystrophy, hip valgus, and decreased joint mobility [1, 2]. The mean age at diagnosis is 2.9 years [1]. The average age of demise for patients with progeria is approximately 12.6 years [1]. Hutchinson-Gilford Progeria is an accelerated aging syndrome caused by mutations in LMNA [3].

Wiedemann-Rautenstrauch syndrome (WRS; OMIM:264090) is a rare autosomal recessive neonatal progeroid disorder that includes some features of premature aging, but it is not caused by laminopathy. WRS is characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance (sparse scalp hair, lipodystrophy, triangular face, pointed chin, and natal teeth), hypotonia, and mental impairment [4]. WRS is mainly caused by biallelic mutations in POLR3A [5,6,7,8]. Recently, a homozygous nonsense variant of POLR3GL has been found to be associated with WRS [9].

Here, we report a proband with WRS. Whole-exome sequencing (WES) of the proband was performed, and compound heterozygous sequence variants of POLR3B were identified. Thus, in addition to previously reported mutations in POLR3A and POLR3GL, in the present study, we identified a novel gene, POLR3B, related to the pathogenesis of WRS.

Case presentation

The proband was a 6-year-old boy. At birth, his weight was 2200 g and length was 50 cm, and his parents were not consanguineous (Fig. 1A). No abnormality was found in the proband during the pregnancy examination of the mother. The proband had multiple postnatal abnormalities, facial dysplasia, micrognathia, skull appearance, hallux valgus, and congenital dislocation of the hip (Fig. 1B-D). The clinical diagnosis was progeria. The mother of the proband underwent regular prenatal examinations during her second pregnancy. Due to being a “pregnant woman in older age, with poor pregnancy history,” the mother of the proband underwent amniocentesis and genetic examination, and no abnormalities were found in the fetus. No abnormality was detected in the fetus following ultrasound at 23 weeks of gestation. The 29-week ultrasound showed that the fetus had a “lemon head”. Magnetic resonance imaging (MRI) of the fetal head showed that the fetal brain was “lemon-shaped” and that the fetal frontal lobe was relatively small. We arranged a pediatric neurosurgery consultation, and the consultation doctors considered the possibility of disability after birth. After discussing with the family and the hospital obstetrician, it was decided to induce labor. The pregnant woman gave birth to a dead girl weighing 1590 g, and the dead girl had abnormal head development (Fig. 1E).

Fig. 1

Pedigree analysis and images of the proband with Wiedemann-Rautenstrauch Syndrome. A The family tree shows the proband (II:1) from a non-consanguineous family. II:2 is the fetus from induced labor. B Facial photograph of the proband at 6 years of age. Physical features include macrocephaly, sparse scalp hair, prominent scalp veins, broad forehead, triangular face, pointed chin, thin upper lip vermilion, and abnormality of the ear. C Photograph of the leg bones of the proband. Physical features include abnormality of the skeletal system and loss of subcutaneous fat from the extremities. D Photograph of the abdomen of the proband. Physical features include lipodystrophy and extreme emaciation. E Photograph of the abortus. Physical features include abnormal head

We first analyzed the pedigree (Fig. 1A) and considered that the disease might have a recessive mode of inheritance. First, CNV sequencing was performed to assess whether there were any CNV perturbations in II:1. We did not identify any chromosome aneuploidy variations or known microdeletion/microduplication variants over 100 kb in II:1 (Supplementary Figure 1A). Therefore, WES was used to determine the genetic causes of II:1. The quality metrics for coverage of the target regions of the exome were satisfactory (Supplementary Table 1). When we analyzed the WES data, we prioritized homozygous variants or compound heterozygous variants. We filtered out the variants with allele frequencies greater than 1% in the databases, including the 1000 Genomes database (1000G, http://browser.1000genomes.org/index.html), the Short Genetic Variations database (dbSNP, http://www.ncbi.nlm.nih.gov/snp/), the Exome Variant Server (ESP6500, http://evs.gs.washington.edu/EVS/), and an in-house database (the retained variants are listed in Supplementary Table 2). Next, we considered that both the proband and aborted fetus had the phenotype of progeria’ therefore, we prioritized the analysis of gene mutations related to progeria, such as in LMNA [3, 10]. However, we did not find any potential pathogenic variants of LMNA in the proband. We also focused on the pathogenic genes of other diseases related to progeria, such as POLR3A [5, 6] and POLR3GL [9], and we only found a heterozygous POLR3A variant, c.1771-6C > A, which is an intron variant, in the WES data. Since the biallelic mutations of POLR3A were pathogenic, the heterozygous intron variant that we found may not be related to the occurrence of the disease. However, we found that the proband carried compound heterozygous variants (NM_018082.5:c.2191G > C:p.E731Q and c.3046G > A:p.V1016M) of POLR3B, which encodes a protein whose function is closely related to that of POLR3A.

Sanger sequencing was used to validate the variants in each member of the pedigree. Both the proband and aborted fetus harbored two variants (Fig. 2A), of which c.2191G > C was inherited from the mother (Fig. 2A) and c.3046G > A was inherited from the father (Fig. 2A).

Fig. 2

Validation and analysis of POLR3B variants. A Sanger sequencing confirmed the compound heterozygous POLR3B variants in the proband and abortus. The father and mother of the porband each carried a heterozygous allele. The red arrows indicate the variant sites. B Domains and variant sites in POLR3B. The full-length protein comprises 1133 amino acids. RNA_pol_Rpb2_1 domain (light blue box); RNA_pol_Rpb2_3 domain (purple box); RNA_pol_Rpb2_4 domain (red box); RNA_pol_Rpb2_5 domain (yellow box); RNA_pol_Rpb2_6 domain (dark blue box); RNA_pol_Rpb2_7 domain (green box). C Sequence alignment of POLR3B in different species. The red arrows indicate the variant sites

To understand the pathogenicity of the two variants, we first conducted bioinformatics analysis. Using online prediction tools, including Polyphen-2, SIFT, PROVEAN, and Mutation Taster, the two variants were considered pathogenic or damaging mutations (Table 1). The predicted results were also supported by the very low allele frequencies of the two mutations in the 1000G and gnomAD databases (Table 1). In addition, we analyzed the conservation of the two variants. Both variants were located in the RNA_pol_Rpb2_6 domain of POLR3B (Fig. 2B). The results of protein sequence alignment analysis revealed that the mutation sites were 100% conserved from humans to zebrafish (Fig. 2B), which indicated that the amino acids at the variant sites were irreplaceable in evolutionary history. The American College of Medical Genetics and Genomics guidelines predicted the two variants as variants of uncertain significance (Table 1).

Table 1 Bioinformatic analysis of the POLR3B variants

We further analyzed the possible pathogenicity of the variant sites by analyzing the structure of POLR3B. The structures of RNA polymerase III and POLR3B are both known (Fig. 3A). POLR3B (Fig. 3B), which is an important subunit of RNA polymerase III, forms the catalytic active center of the polymerase together with POLR3A. The V1016 residue is very important (Fig. 3C) because previous studies have shown that the H1014 and K1019 residues, which are very close to the V1016 residue, are the amino acids that directly interact with nucleotides in POLR3B. Recent findings suggest that the K1019 residue interacts with the template DNA strand and that the H1014 residue interacts with the newly transcribed RNA strand [11]. Therefore, we speculated that V1016M might affect the catalytic activity of RNA polymerase III. The location of the E731 residues provides us with insufficient information regarding the mechanistic processes (Fig. 3D), and more experimental evidence is needed to clarify the involvement of the residues in the pathogenesis of the disease.

Fig. 3

POLR3B structure and mutation site analysis. A Protein complex structure of RNA polymerase III. B POLR3B structure is shown as a cartoon. V1016 and E731 side chains are shown as sticks. C Detailed structural information of the V1016 residue. D Detailed structural information of the E731 residue

Discussion and conclusions

In this study, a patient with progeria phenotype underwent WES, and we found that the patient carried compound heterozygous variants of the POLR3B gene. Based on the genetic variants and the clinical phenotype of the patient, we believe that the patient should be diagnosed with WRS. The genes associated with WRS pathogenesis, identified in previous studies, are POLR3A and POLR3GL [6, 9]. Therefore, POLR3B identified in the present study is a novel pathogenic gene for WRS.

The most prominent feature of WRS is progeria. The clinical phenotype of the proband in this study was progeria; thus, we focused on progeria-related genes in the initial WES analysis. However, we did not find any mutations in LMNA. The advantage of WES over gene panel detection is that it can cover variants of almost all protein-coding genes. Therefore, we began to search for other genetic variants when it was determined that the patient was LMNA mutation-negative. Independent genetic analysis identified compound heterozygous variants of POLR3B. POLR3A variants, which encode proteins closely related to POLR3B in function, can lead to progeria-related WRS. Accordingly, we further confirmed the possibility of POLR3B biallelic variants leading to WRS.

POLR3B is located in the chr 12q23.3 region and consists of 30 exons. POLR3A and POLR3B encode for the largest (RPC1) and second largest (RPC2) subunits of RNA polymerase III, respectively, which are required for the transcription of a subset of non-protein-coding RNAs that includes 5S ribosomal RNA and transfer RNAs (tRNAs) [12]. POLR3A and POLR3B together form the catalytic active center of the polymerase and contribute to the catalytic activity of the polymerase [13]. Therefore, it is reasonable to consider that POLR3A and POLR3B mutations cause similar phenotypes. Previous studies have found that POLR3B mutations can cause hypomyelination, hypodontia, and hypogonadotropic hypogonadism (also known as 4H syndrome) [14,15,16]. We believe that POLR3B mutations that cause 4H syndrome do not interfere with the mutations that cause WRS because numerous studies have reported the mutational spectrum of POLR3A; although biallelic POLR3A mutations have been previously reported in patients with 4H syndrome or spastic ataxia, haplotypes have been detected in WRS patients. Even though there are major differences between 4H and WRS, there is some overlap in disease phenotypes, suggesting that mutations in POLR3A and POLR3B might be related to both diseases. Reduction in the levels of POLR3A or POLR3B leads to perturbation of transcription of the total pool of tRNAs and a deregulated transcription of certain types of ncRNAs [17, 18], could be a molecular mechanism underlying POLR3A or POLR3B mutations. Recently, a sequence variant of POLR3GL has been reported to be associated with WRS [9]. POLR3GL encodes one of the 17 subunits of RNA polymerase III. POLR3GL (RPC32) forms a stable subcomplex together with POLR1C (RPC62) and POLR3F (RPC39). The subcomplex directs RNA polymerase III binding to the TFIIIB-DNA complex via interactions between TFIIIB and POLR3F [19]. Therefore, these results suggest that perturbations in POLR3A, POLR3B, and POLR3GL, which encode three subunits of RNA polymerase III, might be associated with WRS.

In summary, this study not only identified a novel WRS-associated gene, POLR3B, but also enriched the mutational and disease spectra of POLR3B. Furthermore, we believe that next-generation sequencing technology could be very useful for identifying rare disease-related genetic mutations.